A Combined CXCL10, CXCL8 and H-FABP Panel for the Staging of Human African Trypanosomiasis Patients

Background Human African trypanosomiasis (HAT), also known as sleeping sickness, is a parasitic tropical disease. It progresses from the first, haemolymphatic stage to a neurological second stage due to invasion of parasites into the central nervous system (CNS). As treatment depends on the stage of disease, there is a critical need for tools that efficiently discriminate the two stages of HAT. We hypothesized that markers of brain damage discovered by proteomic strategies and inflammation-related proteins could individually or in combination indicate the CNS invasion by the parasite. Methods Cerebrospinal fluid (CSF) originated from parasitologically confirmed Trypanosoma brucei gambiense patients. Patients were staged on the basis of CSF white blood cell (WBC) count and presence of parasites in CSF. One hundred samples were analysed: 21 from stage 1 (no trypanosomes in CSF and ≤5 WBC/µL) and 79 from stage 2 (trypanosomes in CSF and/or >5 WBC/µL) patients. The concentration of H-FABP, GSTP-1 and S100β in CSF was measured by ELISA. The levels of thirteen inflammation-related proteins (IL-1ra, IL-1β, IL-6, IL-9, IL-10, G-CSF, VEGF, IFN-γ, TNF-α, CCL2, CCL4, CXCL8 and CXCL10) were determined by bead suspension arrays. Results CXCL10 most accurately distinguished stage 1 and stage 2 patients, with a sensitivity of 84% and specificity of 100%. Rule Induction Like (RIL) analysis defined a panel characterized by CXCL10, CXCL8 and H-FABP that improved the detection of stage 2 patients to 97% sensitivity and 100% specificity. Conclusion This study highlights the value of CXCL10 as a single biomarker for staging T. b. gambiense-infected HAT patients. Further combination of CXCL10 with H-FABP and CXCL8 results in a panel that efficiently rules in stage 2 HAT patients. As these molecules could potentially be markers of other CNS infections and disorders, these results should be validated in a larger multi-centric cohort including other inflammatory diseases such as cerebral malaria and active tuberculosis.

[1]  K. Kristensson,et al.  Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. , 2009, The Journal of infectious diseases.

[2]  P. Kennedy.  Cytokines in central nervous system trypanosomiasis: cause, effect or both? , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  B. Kampmann,et al.  Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children than IFNγ? , 2008, PloS one.

[4]  P. Kennedy.  The continuing problem of human African trypanosomiasis (sleeping sickness) , 2008, Annals of neurology.

[5]  R. Ned,et al.  Malaria Journal Plasma Ip-10, Apoptotic and Angiogenic Factors Associated with Fatal Cerebral Malaria in India , 2008 .

[6]  E. Aronica,et al.  Astrocytes produce interferon‐alpha and CXCL10, but not IL‐6 or CXCL8, in aicardi‐Goutières syndrome , 2008, Glia.

[7]  P. Kennedy.  Diagnosing central nervous system trypanosomiasis: two stage or not to stage? , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  M. Boivin,et al.  Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. , 2008, The American journal of tropical medicine and hygiene.

[9]  P. Simarro,et al.  Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next> , 2008, PLoS medicine.

[10]  A. MacLeod,et al.  Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response. , 2007, The Journal of infectious diseases.

[11]  Venkatachalam Udhayakumar,et al.  Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children , 2007, Malaria Journal.

[12]  K. Kristensson,et al.  Migration of African trypanosomes across the blood–brain barrier , 2007, Physiology & Behavior.

[13]  J. Brisman,et al.  Reliability of S100B in predicting severity of central nervous system injury , 2007, Neurocritical care.

[14]  R. Romero,et al.  CXCL10/IP-10: A missing link between inflammation and anti-angiogenesis in preeclampsia? , 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[15]  D. Hochstrasser,et al.  Ubiquitin Fusion Degradation Protein 1 as a Blood Marker for The Early Diagnosis of Ischemic Stroke , 2007, Biomarker insights.

[16]  D. T. Wong,et al.  Human body fluid proteome analysis , 2006, Proteomics.

[17]  J. Hau,et al.  IL-10 is up regulated in early and transitional stages in vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense. , 2006, Parasitology international.

[18]  S. Bisser,et al.  A link between chemokine levels and disease severity in human African trypanosomiasis. , 2006, International journal for parasitology.

[19]  J. Rossier,et al.  Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid. , 2006, Journal of proteome research.

[20]  P. Kennedy.  Diagnostic and neuropathogenesis issues in human African trypanosomiasis. , 2006, International journal for parasitology.

[21]  David Pinson,et al.  CXCL10‐induced cell death in neurons: role of calcium dysregulation , 2006, The European journal of neuroscience.

[22]  Human African trypanosomiasis (sleeping sickness): epidemiological update. , 2006, Releve epidemiologique hebdomadaire.

[23]  P. Kennedy,et al.  Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology , 2005, Journal of Neuroimmunology.

[24]  P. Büscher,et al.  Review Article: Cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post‐treatment follow‐up , 2005, Tropical medicine & international health : TM & IH.

[25]  N. Quan,et al.  IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system , 2005, Brain, Behavior, and Immunity.

[26]  F. Chappuis,et al.  Options for Field Diagnosis of Human African Trypanosomiasis , 2005, Clinical Microbiology Reviews.

[27]  T. Giese,et al.  Expression and function of Toll-like receptor 3 in human astrocytes , 2004 .

[28]  S. Giraud,et al.  Endothelial cell activation in the presence of African trypanosomes. , 2005, Molecular and biochemical parasitology.

[29]  J. Sternberg.  Human African trypanosomiasis: clinical presentation and immune response , 2004, Parasite immunology.

[30]  P. Lescuyer,et al.  Identification of post‐mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration , 2004, Proteomics.

[31]  M. Cavaglià,et al.  Peripheral markers of blood-brain barrier damage. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[32]  Jean-Charles Sanchez,et al.  Fatty Acid Binding Protein as a Serum Marker for the Early Diagnosis of Stroke , 2004, Molecular & Cellular Proteomics.

[33]  D. Laskowitz,et al.  Early biomarkers of stroke. , 2003, Clinical chemistry.

[34]  D. Hochstrasser,et al.  A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt‐Jakob disease , 2003, Proteomics.

[35]  H. Reiber,et al.  Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. , 2003, The Journal of infectious diseases.

[36]  S. Kojima,et al.  Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. , 2003, International immunology.

[37]  E. Bosmans,et al.  Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[38]  M. Dziejman,et al.  IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1 , 2002, The Journal of Immunology.

[39]  V. Lejon,et al.  Stage determination and follow-up in sleeping sickness. , 2001, Medecine tropicale : revue du Corps de sante colonial.

[40]  S. Majumder,et al.  Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation , 2000, Immunological reviews.

[41]  P. Büscher,et al.  Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[42]  Jakob S. Jensen,et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.

[43]  J. Baker.  Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. , 1999, World Health Organization technical report series.

[44]  J. Demartino,et al.  Binding and Functional Properties of Recombinant and Endogenous CXCR3 Chemokine Receptors* , 1998, The Journal of Biological Chemistry.

[45]  M. Baggiolini,et al.  Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon‐γ inducible protein‐10 and monocyte chemotactic protein‐1 , 1997, European journal of immunology.

[46]  N. Rothwell,et al.  Cytokines and acute neurodegeneration , 1997, Molecular Psychiatry.

[47]  P. Kennedy,et al.  Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[48]  P. Brecher,et al.  Leakage of heart fatty acid binding protein with ischemia and reperfusion in the rat. , 1989, Journal of molecular and cellular cardiology.

[49]  R. Reneman,et al.  Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. , 1988, Biochimica et biophysica acta.

[50]  Y. Awasthi,et al.  Glutathione S-transferases of human brain. Evidence for two immunologically distinct types of 26500-Mr subunits. , 1985, The Biochemical journal.